JAK2 inhibitor

This page covers all JAK2 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting JAK2.

Targets

JAK2

Phase 2 pipeline (1)

• AT7519M · Astex Pharmaceuticals, Inc. · Oncology
  AT7519M is a potent inhibitor of the JAK2 protein.